PALAIS DES NATIONS • 1211 GENEVA 10, SWITZERLAND
www.ohchr.org • TEL: +41 22 917 9151 / +41 22 917 9 9323 • FAX: +41 22 917 9006 • E-MAIL: hr[email protected]rg
13 June 2022
Open Letter from the Special Rapporteur on contemporary forms of racism, racial
discrimination, xenophobia and related intolerance to the World Trade
Organization’s Twelfth Ministerial Conference
Delegates,
I have the honour to address you in my capacity as the United Nations Special
Rapporteur on contemporary forms of racism, racial discrimination, xenophobia and
related intolerance. I write on the occasion of the World Trade Organization’s Twelfth
Ministerial Conference, namely, the Conference’s consideration of a waiver of certain
provisions of the TRIPS Agreement for the prevention, containment and treatment of
COVID-19.
As an independent expert appointed by the United Nations Human Rights Council
to monitor and report on contemporary manifestations of racism and racial discrimination,
I have closely monitored the global racial inequities exposed and exacerbated by the
COVID-19 pandemic. The pandemic has had disproportionate impacts on Africans and
people of African descent, Asians and people of Asian descent, indigenous peoples,
stateless persons, migrant workers, women, people discriminated against on the basis of
their sexual orientation, gender identity or sex characteristics, persons with disabilities
and many other marginalized groups. I share the conclusion, articulated by several other
international human rights experts,
1
that unequal access to COVID-19 prevention,
containment and treatment technologies (“COVID-19 technologies”) violates the
fundamental human rights principles of equality and non-discrimination.
International trade law, including international intellectual property law,
perpetuates racial discrimination in access to lifesaving COVID-19 vaccines and
medicines. Urgent action is required to remove these legal obstacles to equality and non-
discrimination. I thus urge you to immediately use all tools available to you to rectify
transnational inequities in access to COVID-19 vaccines, treatments and other
technologies. This includes adopting a comprehensive TRIPS waiver under the terms
prominently proposed by certain WTO Members and civil society. International human
rights law requires the prohibition of racial discrimination as a matter of both treaty-based
and customary international law. Under these obligations, shared by all WTO Members,
the organization must be attuned to the current unequal distribution of life-saving
COVID-19 technologies, which disproportionately affects the world’s racially
marginalized peoples.
1
See “States must prioritize health and equality over profits and vaccine hoarding, UN experts
say”, 29 November 2021; “Statement by UN Human Rights Experts Universal access to
vaccines is essential for prevention and containment of COVID-19 around the world”, 9
November 2020; Tlaleng Mofokeng, “UN expert strives to make right to health a reality for all”,
23 June 2021.
PAGE 2
Unequal access to COVID-19 vaccines and other COVID-19 technologies within
and across nations is undeniably an issue of racial injustice. Racism, racial discrimination,
xenophobia and related intolerance operate through both: (1) differential treatment of and
outcomes for individuals and groups on the grounds of their race, colour, descent, national
or ethnic origin; and (2) differential treatment of and outcomes for countries and
territories that were subject to prolonged exploitation and degradation during the colonial
era on the basis of racist theories and beliefs.
2
The Committee on the Elimination of Racial Discrimination (“CERD”) has
highlighted how the disproportionate impact of COVID-19 between and within countries
reproduces colonial hierarchies and represents the international community’s failure “to
redress the effects of racism rooted in slavery, colonialism and apartheid.
3
Certain
“developed” nations and powerful transnational corporations based within their
jurisdictions have monopolized authority to determine “who is worth saving” — and this
hierarchical power cannot be unlinked from its colonial origins. Researchers have
observed that “[t]he map of winners and losers in the COVID-19 vaccination race appears
almost indistinguishable from the map of European colonialism”.
4
Additionally, the
relative financial burden of reaching the target vaccination rate of 70 per cent has been as
large as 71 times higher for low income countries compared to high income countries.
5
The uneven multilateral playing field has thus generated a “two-track pandemic”,
6
in
which certain countries are “plunged into multiple interlinked emergencies a debt crisis,
a development crisis and a human rights crisis.”
7
The term “vaccine apartheid” aptly
describes the regime that has been in place for much of the pandemic.
In addition to curtailed access to COVID-19 vaccines, intellectual property
barriers have limited the supply of COVID-19 diagnostic technologies and therapeutic
treatments. Monopolies over the creation and supply of COVID-19 technologies have
exacerbated shortages for low-income nations, with States in a position to materially
transform the situation failing to do so.
CERD’s April 2022 statement, issued under its Early Warning and Urgent Action
Procedure, provides a comprehensive account of racially discriminatory COVID-19
outcomes within and between States. But CERD is not alone in identifying the unjust
nature of the current COVID-19 status quo. In fact, there is broad consensus throughout
the United Nations system that the current approach is untenable from a legal and moral
perspective. This consensus is captured in the findings and statements of, among others,
various Human Rights Council Special Procedures mandate holders,
8
Tedros Adhanom
2
I have made this point in several reports to the United Nations Human Rights Council and
General Assembly. See, e.g., A/HRC/41/54.
3
Committee on the Elimination of Racial Discrimination, “Statement on the lack of equitable
and non-discriminatory access to COVID-19 vaccines”, statement at the 106
th
session of CERD
(April 2022).
4
Tammam Aloudat, Dena Arjan Kirpalani and Meg Davis, “Decolonisation and Global
Health”, Geneva Graduate Institute, October 2021.
5
UNDP, Global Dashboard for Vaccine Equity. Available at https://data.undp.org/vaccine-
equity/
6
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, media
briefing on COVID-19, Geneva, 7 June 2021.
7
Michelle Bachelet, United Nations High Commissioner for Human Rights, statement to the
49th session of the Human Rights Council, Geneva, 11 March 2022.
8
See, for example, the statements included in footnote 1.
PAGE 3
Ghebreyesus, the Director-General of the World Health Organization,
9
Michelle
Bachelet, UN High Commissioner for Human Rights,
10
Winnie Byanyima, UN
Undersecretary-General and Executive Director of UNAIDS,
11
and UN Secretary-
General António Guterres.
12
I am aware that certain Members have opposed the proposal by India and South
Africa in October 2020 (revised May 2021) temporarily to waive intellectual property
protections under TRIPS for healthcare technologies involving COVID “prevention,
containment or treatment”. News reports have emerged that a compromise reached in
March 2022 is geographically limited and only covers vaccine production. The former
UN Secretary-General Ban Ki-Moon has gone so far as to identify the proposed text as
inadequate, calling it a “half measure”.
13
Racial injustice is a defining challenge of our times. Systemic racial
discrimination is embedded into transnational legal, economic and political structures,
including the international intellectual property regime. These systems uphold racial
inequality by constraining the possible solutions for challenging such inequality. In the
context of the COVID-19 pandemic, this has meant that the burdens of the pandemic have
been borne disproportionately by certain States, peoples and territories most harmed by
colonialism and racism, while the mechanisms for reducing these burdens are controlled
almost entirely by States, peoples and territories which were the beneficiaries of
colonialism.
In the face of this monumental challenge and deeply entrenched historical
inequality, half-measures and weak compromises are not enough. It is notable that many
of the WTO Members now resisting a full TRIPS waiver were on the forefront of
denouncing systemic racial discrimination in the aftermath of the 2020 racial justice
uprisings. At that time, they called for the cooperation of all nations and all peoples in
eradicating racial inequality and systemic racism. Delegates, I urge you to honor those
commitments and the legal obligations for equality and non-discrimination enshrined in
international human rights law. It is my hope that you will demonstrate, through your
actions at this Twelfth Ministerial Conference, the political willpower, leadership and
firm commitment to racial equality that transformative change requires.
If I can offer any clarification on the above, or if I can be of further assistance on
any issues related to my mandate, please do not hesitate to contact me through the Office
of the High Commissioner for Human Rights (Ms. Eleanor Robb, eleanor[email protected]).
Please accept, distinguished Delegates, the assurances of my highest regard.
9
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, media
briefing on COVID-19, Geneva, 7 June 2021.
10
Michelle Bachelet, United Nations High Commissioner for Human Rights, statement to the
49th session of the Human Rights Council, Geneva, 11 March 2022.
11
“UN Undersecretary-General Says Failure to Share COVID-19 Vaccines with Global South
‘Is Racism’”, World Economic Forum, 25 May 2022.
12
António Guterres, Secretary-General of the United Nations, video remarks to the high-level
thematic debate on “Galvanizing Momentum for Universal Vaccination”, in New York, 25
February 2022.
13
Ban Ki-Moon, “India, South Africa must not accept half-measures by the West when lives are
on line during Covid-19 pandemic”, The Times of India, 24 March 2022.
PAGE 4
E. Tendayi Achiume
Special Rapporteur on Contemporary Forms of Racism, Racial Discrimination,
Xenophobia and Related Intolerance